TriMas Co. (NASDAQ:TRS) Shares Bought by Rhumbline Advisers

Rhumbline Advisers grew its stake in shares of TriMas Co. (NASDAQ:TRS) by 1.4% in the second quarter, according to its most recent filing with the SEC. The fund owned 69,328 shares of the industrial products company’s stock after acquiring an additional 985 shares during the period. Rhumbline Advisers owned about 0.17% of TriMas worth $1,772,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Innealta Capital LLC acquired a new stake in TriMas during the second quarter valued at $26,000. Bank of New York Mellon Corp increased its stake in shares of TriMas by 8.2% in the second quarter. Bank of New York Mellon Corp now owns 262,294 shares of the industrial products company’s stock worth $6,704,000 after purchasing an additional 19,849 shares during the period. Diversified Trust Co increased its stake in shares of TriMas by 5.0% in the second quarter. Diversified Trust Co now owns 22,719 shares of the industrial products company’s stock worth $581,000 after purchasing an additional 1,072 shares during the period. Kennedy Capital Management LLC increased its stake in TriMas by 197.8% during the first quarter. Kennedy Capital Management LLC now owns 273,200 shares of the industrial products company’s stock valued at $7,303,000 after acquiring an additional 181,447 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in TriMas by 6.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company’s stock valued at $639,000 after acquiring an additional 1,478 shares during the period. Hedge funds and other institutional investors own 99.42% of the company’s stock.

TriMas Stock Performance

TRS stock opened at $25.45 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.82 and a quick ratio of 1.48. The company has a 50 day moving average price of $25.07 and a 200 day moving average price of $25.66. TriMas Co. has a fifty-two week low of $22.45 and a fifty-two week high of $27.89. The stock has a market capitalization of $1.03 billion, a PE ratio of 26.24 and a beta of 0.68.

TriMas (NASDAQ:TRS) last issued its earnings results on Tuesday, July 30th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.10). TriMas had a return on equity of 9.61% and a net margin of 4.44%. The company had revenue of $240.50 million for the quarter, compared to the consensus estimate of $238.63 million. During the same quarter last year, the business posted $0.50 EPS. TriMas’s quarterly revenue was up 3.1% on a year-over-year basis. Analysts forecast that TriMas Co. will post 1.76 EPS for the current year.

TriMas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 13th. Stockholders of record on Tuesday, August 6th were issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.63%. The ex-dividend date was Tuesday, August 6th. TriMas’s dividend payout ratio (DPR) is presently 16.49%.

Analysts Set New Price Targets

Separately, BWS Financial reissued a “buy” rating and issued a $40.00 target price on shares of TriMas in a report on Wednesday, July 31st.

TriMas Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.